Verona Pharma (VRNA)
(Real Time Quote from BATS)
$13.32 USD
-0.04 (-0.30%)
Updated May 17, 2024 10:58 AM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | -33.33% |
ABR | 1.00 |
Earnings ESP
|
0.29% |
---|---|
Current Year | -1.47 |
Next Year | -1.23 |
EPS (TTM) | -0.77 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 6.95M | 14.32M | 95.66M |
# of Estimates | NA | 5 | 5 | 5 |
High Estimate | NA | 15.70M | 31.47M | 168.50M |
Low Estimate | NA | 0.75M | 2.25M | 36.53M |
Year ago Sales | 0.00M | 0.00M | 0.46M | 14.32M |
Year over Year Growth Est. | NA | NA | 3,026.64% | 568.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.36 | -1.47 | -1.23 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.32 | -0.28 | -1.36 | -0.88 |
High Estimate | -0.32 | -0.24 | -1.16 | -0.59 |
Low Estimate | -0.40 | -0.56 | -1.84 | -1.76 |
Year ago EPS | -0.11 | -0.18 | -0.72 | -1.47 |
Year over Year Growth Est. | -218.18% | -100.00% | -104.17% | 15.92% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 2 | 2 | 4 | 4 |
Down Last 60 Days | 2 | 3 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.36 | -1.47 | -1.23 |
7 Days Ago | -0.35 | -0.36 | -1.45 | -1.14 |
30 Days Ago | -0.32 | -0.34 | -1.32 | -0.85 |
60 Days Ago | -0.32 | -0.33 | -1.23 | -0.61 |
90 Days Ago | -0.26 | -0.28 | -0.97 | -0.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.33 | -1.54 | -1.39 |
Zacks Consensus Estimate | -0.35 | -0.36 | -1.47 | -1.23 |
Earnings ESP | 0.29% | 10.22% | -5.22% | -13.03% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.16 | -0.18 | -0.11 | NA |
Estimate | -0.24 | -0.23 | -0.27 | -0.27 | NA |
Difference | -0.08 | 0.07 | 0.09 | 0.16 | 0.06 |
Surprise | -33.33% | 30.43% | 33.33% | 59.26% | 22.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more